Buy or sell Pivot Bio stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Pivot Bio Stock
Agricultural Technology
About Pivot Bio Stock
Investors
Bill & Melinda Gates Foundation
Apeel Sciences, Pivot Bio, Butterfly Network, Schrodinger, Evolve Biosystems, Heliogen
Breakthrough Energy Ventures
Nature's Fynd, QuantumScape, Pivot Bio, Turntide Technologies
Bunge Ventures
Codon Capital
Continental Grain Company
Generation Investment Management
DocuSign, Nature's Fynd, Proterra, Pivot Bio, Remitly, Optoro, Guideline, Andela, Asana
Genoa Ventures
Monsanto Growth Ventures (MGV)
OS Fund
Pivot Bio, Emulate, Tempo Automation, Human Longevity, Verge Genomics, Elysium Health, uBiome, 3T Biosciences
Pavilion Capital
Prelude Ventures, LLC
Rockefeller Capital Management
Tekfen Ventures
Temasek Holdings
PharmEasy, Tokopedia, DoorDash, Impossible Foods, Wish, AvidXchange, SambaNova Systems, Snyk, Farmers Business Network, ConsenSys
Funding History
| October 2014 | $1000K |
|---|---|
| March 2016 | $16.0M |
| September 2018 | $71.3M |
| April 2020 | $105M |
| July 2021 | $435M |
Management
Chief Executive Officer
Karsten Temme
Chief Financial Officer
Doug Jeffries
Press
TechCrunch - Jul, 20 2021
wsj - Jul, 21 2021
agfundernews - Jul, 19 2021
prnewswire - Jul, 19 2021
ow - Mar, 10 2021
agfundernews - Apr, 30 2020
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
